2) Lung
cancer is caused by several reasons. The first is the daily cigarette
consumption and air pollution. The smoke contains toxic chemicals that are
released in the smoke that smokers produce. “The chemicals accumulate in the
lungs and eventually cause cell damage”. And also de passive smokers can had a
long cancer because the smoke of the smokers is in the air and a passive smoker
can inhale and be contaminate. Another
Long cancer reason is Endogenous factors, Industrial
risks, urban pollution and atmospheric, Scarring: bronchial pathology prior and
virus.
4.- The therapies that can be used in lung cancer are generally the Biological therapy; this therapy can control or stop the growth of cancer cells. This type of Biological therapy can treat the two types of lung cancer (SCLC and NSCLC). The doctors of this treatment use many types of drugs, including: erlotinib (Tarceva), gefitinib (Iressa) and crizotinib (Xalcori). The erlotinib, knowed by his brand name Tarceva, works by blocking particular proteins called epidermal growth factor receptors (EGFR) that works in the cancer cells. The gefitinib has the brand name Iressa, it also works blocking the epidermal growth factor receptors, the gefitinib is the number 1 treatment recommended to the NSCLC. The crizotinib with the brand name Xalcori, only works helping the advanced NSCLC in people that the cancer cells have an overactive version of a protein called anaplastic lymphoma kinase (ALK).
4.- The therapies that can be used in lung cancer are generally the Biological therapy; this therapy can control or stop the growth of cancer cells. This type of Biological therapy can treat the two types of lung cancer (SCLC and NSCLC). The doctors of this treatment use many types of drugs, including: erlotinib (Tarceva), gefitinib (Iressa) and crizotinib (Xalcori). The erlotinib, knowed by his brand name Tarceva, works by blocking particular proteins called epidermal growth factor receptors (EGFR) that works in the cancer cells. The gefitinib has the brand name Iressa, it also works blocking the epidermal growth factor receptors, the gefitinib is the number 1 treatment recommended to the NSCLC. The crizotinib with the brand name Xalcori, only works helping the advanced NSCLC in people that the cancer cells have an overactive version of a protein called anaplastic lymphoma kinase (ALK).
5) The possibilities of recover of the long cancer depends of your grade of your tumour if is really advanced is very difficult to cure, bad if the cancer is “new” you have a big chance of survive. The traditional medicine has a lot of treatment to do de recuperation more possible like pharmaceutical and chemotherapy.
6) There are no remedies only treatments and surgeries if the
cancer is in face 1 (joust beginning) you can make a surgeries but if is in a
hire level you have to do like a chemotherapy pre other treatments. That are like the
remedies to cure Long Cancer.
The cost have been difficult to measure. The primary
obstacle to quantification is the intermittent and long term nature of
treatment for this disease. A complete record of expenses cannot usually be
obtained from one source, however, a review of all the national health surveys,
as well as the Medicare, which is maintained by the Health Care Financing
Administration in a format suitable for calculation of cumulative medical
expenses . The lifetime cost of treating lung cancer is $ 12.510.
8.-Do health programs in Chile cover this treatment
expenses? How about health programs of USA, New Zealand, Australia or any
European country? ( you can refer to only one) ( 10 lines minimum)
In Chile, we
have the AUGE plan which is a national law N°19.966 for all Chilean to have
their health program guaranteed by the Government.
Doctor Sergio Kleinman says that this cancer is not
considered in AUGE plan yet, but lung cancer surgery it is covered by the public and private
system. The problem are the treatments for lung cancer patients.
.
In the USA cancer
health disparities are not only an economic and medical concern but also a
moral and ethical dilemma for the USA-
Many problems such financial and geographic barriers
to treatment; ineffective provider patient communication; inadequate screening,
and insufficient post treatment and long term follow up can occur in varying
combination over time, resulting in increased lung cancer related costs. In the
USA, one thing has become clear : social injustice leading to unfair inequities
are most part of these problems.
The NATIONAL CANCER INSTITUTE, part of the National
Institute of Health and the Department of Health and Human Services, is the
Nation´s principal agency for cancer research and coordinates the National
Cancer Program.
As a federal agency, NATIONAL CANCER INSTITUTE
receives its funds from Congress. The NCI´s busget has been approximately $ 4.9
billion per year.
Other federal agencies, state and local governments,
voluntary organizations, private institutions, and industry spend substantial
amounts of money trying hard to help cancer patients, their treatments, drugs
and others.
9.- REFER TO ONE REAL TESTIMONY TO SUPPORT YOURS
FINDINGS. INCLUDE AS MUCH INFORMATION AS POSSIBLE .- ( no extension required)
www.lungcancercanada.ca/patient-arthur-smith.aspx
No hay comentarios:
Publicar un comentario